Minapharm Pharmaceuticals posts 77% consolidated profit surge in Q1 2020

The company’s net sales amounted to $34.12mln

  

Cairo –  The consolidated financial statements of Minapharm Pharmaceuticals reported a 77.3% year-on-year (YoY) profit growth to EGP 75.25 million during the first quarter of 2020, compared to EGP 42.42 million, including minority shareholders’ rights.

The company’s net sales amounted to EGP 551.01 million in the January-March period from EGP 522.19 million in the prior-year period, according to a statement to the Egyptian Exchange (EGX) on Monday.

Previously, the company’s standalone financial results showed net profits of EGP 18.5 million, up by 185% YoY from EGP 6.48 million.

It is worth mentioning that in 2019, the company posted net profits of EGP 148.41 million, compared to EGP 124.24 million a year earlier.

Source: Mubasher

All Rights Reserved - Mubasher Info © 2005 - 2020 Provided by SyndiGate Media Inc. (Syndigate.info).

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.

More From Equities